European Neurologists Expect Significant Increases In The Use Of Both Tysabri And Extavia In Their Multiple Sclerosis Patients The Next Six Months
Links shared publicly online about this topic.
- 622total visits
European Neurologists Expect Significant Increases In The Use Of Both Tysabri And Extavia In Their Multiple Sclerosis Patients The Next Six Months
BioTrends Research Group, Inc. finds that while neurologists in the EU tend to prescribe the established interferon betas as their first line disease modifying agents (DMAs) for the treatment of m
View full resource at medicalnewstoday.com
Tags: Neurology, Multiple Sclerosis, Disease and Condition, Tysabri, Neurologist, disease
Most Recently Shared on December 29, 2010 at 7:03 pm By:
European Neurologists Expect Significant Increases In The Use Of Both Tysabri And Extavia In Their Multiple Scle... http://mnt.to/f/3PwR
Also Shared By:
Advertisement
MNT Multiple Scl
@mnt_multiplescl
European Neurologists Expect Significant Increases In The Use Of Both Tysabri And Extavia In Their Multiple Sclerosis ... http://mnt.to/3PwR
1 year ago...